Detalles de la búsqueda
1.
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro.
Br J Cancer
; 130(8): 1365-1376, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38396172
2.
The effect of O-antigen length determinant wzz on the immunogenicity of Salmonella Typhimurium for Escherichia coli O2 O-polysaccharides delivery.
Vet Res
; 54(1): 15, 2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36849993
3.
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
J Cell Mol Med
; 24(13): 7550-7562, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452133
4.
Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway.
Korean J Physiol Pharmacol
; 24(3): 193-201, 2020 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32392910
5.
ONC201/TIC10 Is Empowered by 2-Deoxyglucose and Causes Metabolic Reprogramming in Medulloblastoma Cells in Vitro Independent of C-Myc Expression.
Front Cell Dev Biol
; 9: 734699, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34900991
6.
The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma.
J Exp Clin Cancer Res
; 38(1): 219, 2019 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31122294
Resultados
1 -
6
de 6
1
Próxima >
>>